Kristin Köhler‐Forsberg

Author

University of Copenhagen

Also Known As

K. Köhler-Forsberg, K.L. Köhler-Forsberg, Kristin Kohler-Forsberg, Kristin Köhler-Forsberg, Kristin Köhler‐Forsberg

Publications

352

Citations

H-Index

Concepts

All Affiliations

University of Copenhagen Rigshospitalet Copenhagen University Hospital Lundbeck (Denmark)Capital Region of Denmark

About

Kristin Köhler‐Forsberg is an author at University of Copenhagen specializing in neuroscience, medicine, and major depressive disorder.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	53
2	Social Sciences	2	2	53
3	Neuroscience	2	2	53
4	Psychiatry	2	2	53
5	Neurology	1	1	33

Kristin Köhler‐Forsberg

Publications

325

Citations

H-Index

Page 1

	Year	Citations
Predicting Treatment Outcome in Major Depressive Disorder Using Serotonin 4 Receptor PET Brain Imaging, Functional MRI, Cognitive-, EEG-Based, and Peripheral Biomarkers: A NeuroPharm Open Label Clinical Trial Protocol Kristin Köhler‐Forsberg, Anders Jorgensen, Vibeke H. Dam, Frontiers in Psychiatry	2020	64
Serotonin 4 Receptor Brain Binding in Major Depressive Disorder and Association With Memory Dysfunction Kristin Köhler‐Forsberg, Vibeke H. Dam, Brice Ozenne, JAMA Psychiatry	2023	37
Pretreatment qEEG biomarkers for predicting pharmacological treatment outcome in major depressive disorder: Independent validation from the NeuroPharm study Cheng-Teng Ip, Sebastian Olbrich, Melanie Ganz, European Neuropsychopharmacology PsychiatryPsychotropic MedicationNeurophysiological BiomarkersDepressionPsychopharmacology	2021	33
Hot and cold cognitive disturbances in antidepressant-free patients with major depressive disorder: a NeuroPharm study Vibeke H. Dam, Dea Siggaard Stenbæk, Kristin Köhler‐Forsberg, Psychological Medicine	2020	32
Systemic DNA and RNA damage from oxidation after serotonergic treatment of unipolar depression Anders Jørgensen, Kristin Köhler‐Forsberg, Trine Henriksen, Translational Psychiatry	2022	26
Evaluating cognitive disturbances as treatment target and predictor of antidepressant action in major depressive disorder: A NeuroPharm study Vibeke H. Dam, Dea Siggaard Stenbæk, Kristin Köhler‐Forsberg, Translational Psychiatry	2022	26
NeuroPharm study: EEG wakefulness regulation as a biomarker in MDD Cheng-Teng Ip, Melanie Ganz, Vibeke H. Dam, Journal of Psychiatric Research	2021	25
Concurrent anxiety in patients with major depression and cerebral serotonin 4 receptor binding. A NeuroPharm-1 study Kristin Köhler‐Forsberg, Brice Ozenne, Søren Vinther Larsen, Translational Psychiatry	2022	25
Reward processing in major depressive disorder and prediction of treatment response – Neuropharm study Ida Marie Brandt, Kristin Köhler‐Forsberg, Melanie Ganz, European Neuropsychopharmacology Reward ProcessingPsychiatryMood SymptomAffective NeuroscienceDepression	2021	20
The Impact of Hormonal Contraceptive Use on Serotonergic Neurotransmission and Antidepressant Treatment Response: Results From the NeuroPharm 1 Study Søren Vinther Larsen, Brice Ozenne, Kristin Köhler‐Forsberg, Frontiers in Endocrinology	2022	16

Page 1